Status
Conditions
Treatments
About
The Efficacy of Clenpiq utilized per FDA labeling, with a low residue diet the day before colonoscopy.
Full description
This study proposes to assess the use of a low residue diet of a prescribed nature the day before colonoscopy for breakfast, lunch and early dinner. Clinical outcomes utilizing the low residue diet will be compared to the Food and Drug Administration (FDA) approved split dose labeling, including the traditional clear liquid diet the day before colonoscopy utilizing the Clenpiq (Ferring Pharmaceuticals) bowel preparation.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Additional exclusion criteria would include;
Primary purpose
Allocation
Interventional model
Masking
154 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal